These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
182 related items for PubMed ID: 24659164
1. The persian version of the chronic urticaria quality of life questionnaire: factor analysis, validation, and initial clinical findings. Tavakol M, Mohammadinejad P, Baiardini I, Braido F, Gharagozlou M, Aghamohammadi A, Nabavi M, Dabbaghzade A, Tavakol Z, Afarideh M, Rezaei N. Iran J Allergy Asthma Immunol; 2014 Aug; 13(4):278-85. PubMed ID: 24659164 [Abstract] [Full Text] [Related]
2. Turkish version of the chronic urticaria quality of life questionnaire: cultural adaptation, assessment of reliability and validity. Kocatürk E, Weller K, Martus P, Aktas S, Kavala M, Sarigul S, Baiardini I, Canonica GW, Brzoza Z, Kalogeromitros D, Maurer M. Acta Derm Venereol; 2012 Jul; 92(4):419-25. PubMed ID: 21918791 [Abstract] [Full Text] [Related]
3. Adaptation and validation of the Spanish version of the Chronic Urticaria Quality of Life Questionnaire (CU-Q2oL). Valero A, Herdman M, Bartra J, Ferrer M, Jáuregui I, Dávila I, del Cuvillo A, Montoro J, Mullol J, Sastre J, Canonica GW, Baiardini I. J Investig Allergol Clin Immunol; 2008 Jul; 18(6):426-32. PubMed ID: 19123433 [Abstract] [Full Text] [Related]
4. Minimal clinical important difference (MCID) of the Thai Chronic Urticaria Quality of Life Questionnaire (CU-Q2oL). Kulthanan K, Chularojanamontri L, Tuchinda P, Rujitharanawong C, Baiardini I, Braido F. Asian Pac J Allergy Immunol; 2016 Jun; 34(2):137-45. PubMed ID: 27007835 [Abstract] [Full Text] [Related]
5. Cross-cultural adaptation of the Brazilian-Portuguese version of the chronic urticaria quality-of-life questionnaire - CU-Q2oL. Dias GA, Pires GV, Valle SO, França AT, Papi JA, Dortas SD, Levy SA, Baiardini I, Canonica GW. Allergy; 2011 Nov; 66(11):1487-93. PubMed ID: 21899558 [Abstract] [Full Text] [Related]
6. Adaptation and Validation of the Israeli Version of the Chronic Urticaria Quality of Life Questionnaire (CU-Q2oL). Kessel A, Graif Y, Vadasz Z, Schichter-Konfino V, Almog M, Cohen S, Teplitski V, Stein N, Baiardini I, Maurer M, Toubi E. Isr Med Assoc J; 2016 Aug; 18(8):461-465. PubMed ID: 28471576 [Abstract] [Full Text] [Related]
7. Adaptation and validation of the Bengali version of the Chronic Urticaria Quality of Life Questionnaire (CU-Q2oL). Dhabal A, Mondal H, Mondal S, Baiardini I, Chakraborty SS, Chakraborty T, Podder I. Indian J Dermatol Venereol Leprol; 2023 Aug; 89(3):385-392. PubMed ID: 36331856 [Abstract] [Full Text] [Related]
8. The Arabic Urticaria Activity Score and Chronic Urticaria Quality of Life Questionnaire: validation and correlations. Tawil S, Irani C, Kfoury R, Salameh P, Baiardini I, Weller K, Maurer M, Ezzedine K. Int J Dermatol; 2020 Aug; 59(8):893-901. PubMed ID: 32638368 [Abstract] [Full Text] [Related]
9. Disease activity only moderately correlates with quality of life impairment in patients with chronic spontaneous urticaria. Koti I, Weller K, Makris M, Tiligada E, Psaltopoulou T, Papageorgiou C, Baiardini I, Panagiotakos D, Braido F, Maurer M. Dermatology; 2013 Aug; 226(4):371-9. PubMed ID: 23942323 [Abstract] [Full Text] [Related]
10. Clinical evaluation of the computerized chronic urticaria-specific quality of life questionnaire in Korean patients with chronic urticaria. Ye YM, Park JW, Kim SH, Choi JH, Hur GY, Lee HY, Lee EH, Park HS. Clin Exp Dermatol; 2012 Oct; 37(7):722-8. PubMed ID: 22731761 [Abstract] [Full Text] [Related]
11. Psychometric properties of the portuguese version of the chronic urticaria quality of life questionnaire (CU-Q2oL). Ferreira PL, Gonçalo M, Ferreira JA, Costa AC, Todo-Bom A, Abreu CL, Travassos AR, Andrade P, Baiardini I, Canonica GW. Health Qual Life Outcomes; 2019 Dec 30; 17(1):190. PubMed ID: 31888747 [Abstract] [Full Text] [Related]
12. Chinese version of the chronic urticaria quality of life questionnaire: cultural adaptation, factor analysis, assessment of reliability and validity. Zhao Z, Zhang C, Jiang Y, Peng C, Zhu W, Zhao S, Chen X, Li J. Arch Dermatol Res; 2022 Nov 30; 314(9):847-855. PubMed ID: 34739561 [Abstract] [Full Text] [Related]
13. The German version of the Chronic Urticaria Quality-of-Life Questionnaire: factor analysis, validation, and initial clinical findings. Młynek A, Magerl M, Hanna M, Lhachimi S, Baiardini I, Canonica GW, Brzoza Z, Kasperska-Zajac A, Rogala B, Zalewska-Janowska A, Zuberbier T, Maurer M. Allergy; 2009 Jun 30; 64(6):927-36. PubMed ID: 19453340 [Abstract] [Full Text] [Related]
14. Psychometric properties of the Spanish version of the once-daily Urticaria Activity Score (UAS) in patients with chronic spontaneous urticaria managed in clinical practice (the EVALUAS study). Jauregui I, Gimenez-Arnau A, Bartra J, Labrador-Horrillo M, de Frutos JO, Silvestre JF, Sastre J, Velasco M, Ferrer M, Ballesteros C, Valero A. Health Qual Life Outcomes; 2019 Jan 31; 17(1):23. PubMed ID: 30704532 [Abstract] [Full Text] [Related]
15. Validity and reliability of the Indonesian version of the Chronic Urticaria Quality of Life Questionnaire (CU-Q2oL). Nuary T, Budianti WK, Indriatmi W, Baiardini I. Asian Pac J Allergy Immunol; 2021 Jul 11. PubMed ID: 34246221 [Abstract] [Full Text] [Related]
16. Evaluation of the Reliability and Validity of the Persian Version of Urticaria Control Test (UCT). Khoshkhui M, Weller K, Fadaee J, Maurer M, Jabbari Azad F, Emadzadeh M. Iran J Allergy Asthma Immunol; 2021 Aug 07; 20(4):423-431. PubMed ID: 34418896 [Abstract] [Full Text] [Related]
17. Improvement in the quality of life of patients with chronic spontaneous urticaria treated with omalizumab in real life. Larrea-Baca I, Gurpegui-Resano M. Enferm Clin; 2017 Aug 07; 27(6):361-368. PubMed ID: 28457893 [Abstract] [Full Text] [Related]
18. A new tool to evaluate the impact of chronic urticaria on quality of life: chronic urticaria quality of life questionnaire (CU-QoL). Baiardini I, Pasquali M, Braido F, Fumagalli F, Guerra L, Compalati E, Braga M, Lombardi C, Fassio O, Canonica GW. Allergy; 2005 Aug 07; 60(8):1073-8. PubMed ID: 15969690 [Abstract] [Full Text] [Related]
19. The impact of omalizumab on quality of life and its predictors in patients with chronic spontaneous urticaria: Real-life data. Salman A, Demir G, Bekiroglu N. Dermatol Ther; 2019 Jul 07; 32(4):e12975. PubMed ID: 31145524 [Abstract] [Full Text] [Related]
20. Validation of the Persian version of the fear avoidance belief questionnaire in patients with low back pain. Rostami M, Noorian N, Mansournia MA, Sharafi E, Babaki AE, Kordi R. J Back Musculoskelet Rehabil; 2014 Jul 07; 27(2):213-21. PubMed ID: 24254494 [Abstract] [Full Text] [Related] Page: [Next] [New Search]